Infantile myofibromatosis: a series of 28 cases.

J Am Acad Dermatol

Department of Dermatology, Groupe Hospitalier Necker-Enfants Malades, Assistance Publique, Hôpitaux de Paris, Paris, France; Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), Groupe Hospitalier Necker-Enfants Malades, Assistance Publique, Hôpitaux de Paris, Paris, France; Université Paris Descartes - Sorbonne Paris Cité, Institut Imagine, Paris, France. Electronic address:

Published: August 2014

Background: Infantile myofibromatosis (IM) is a rare disorder of fibroblastic/myofibroblastic proliferation in children.

Objectives: We sought to document common and unusual characteristics of patients with IM.

Methods: This was a retrospective study of 28 children diagnosed with histopathologically confirmed IM between 1992 and 2012. Epidemiologic, clinical, and treatment data were reviewed.

Results: IM was more frequent in boys (60.8%). Skin lesions were congenital in 64.3% of cases. The solitary form accounted for 50% of cases. Most nodules were painless, arising in cutaneous or subcutaneous tissue. The multicentric form accounted for 39% of cases; the skin, subcutaneous tissue, or muscle was involved in 97.8% of cases, and the bones in 50% of cases. The generalized form had a mortality rate of 33% (one-third of cases). Multicentric and generalized forms regressed spontaneously; severe local complications were observed, and late recurrent nodules developed in a few cases.

Limitations: The retrospective review and the ascertainment of patients (from the departments of obstetrics and pediatrics) may have introduced bias in the analysis of severity of the different forms of IM.

Conclusion: The diagnosis of IM must be confirmed histopathologically because the clinical presentation can be misleading. The prognosis is usually good, although local morbidity can occur. The generalized and multicentric forms merit long-term follow-up.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.03.035DOI Listing

Publication Analysis

Top Keywords

infantile myofibromatosis
8
form accounted
8
50% cases
8
subcutaneous tissue
8
cases
7
myofibromatosis series
4
series cases
4
cases background
4
background infantile
4
myofibromatosis rare
4

Similar Publications

Purpose: Infantile myofibromatosis is characterized by the development of myofibroblastic tumors in young children. In most cases, the disease is caused by somatic gain-of-function variants in platelet-derived growth factor (PDGF) receptor beta (PDGFRB). Here, we reported a novel germline intronic PDGFRB variant, c.

View Article and Find Full Text PDF

Adult recurrence of infantile myofibromatosis is exceptional. Here, we report the case of a 23-year-old woman with a late recurrence of infantile myofibromatosis revealed by spontaneous pneumothorax. The chest computed tomography scan found both cavitary and nodular bilateral pulmonary lesions.

View Article and Find Full Text PDF

Infantile myofibromatosis is a proliferative disorder occurring during infancy and early childhood, marked by the development of nodular or diffuse lesions consisting of various mesenchymal elements. Intracranial involvement is infrequently reported. Here, we present the case of a 3-year-old girl exhibiting a rare manifestation of IM with intracranial parenchymal involvement, displaying a histological pattern documented in existing literature on patients with infantile myofibromatosis.

View Article and Find Full Text PDF

Background: Infantile myofibromatosis (IM) is a rare disorder characterized by benign tumors in the skin, subcutaneous tissue, muscle, and occasionally viscera. IM can be hereditary due to PDGFRB or NOTCH3 variants. Treatment is mainly conservative or surgical.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!